Ascendance Biotechnology Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Ascendance Biotechnology Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10363
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ascendance Biotechnology Inc (Ascendance), formerly Hepregen Corp is a healthcare products provider that offers cell based assay products. The company’s products include human HepatoMune kits, HepatoPac B-CLEAR transporter kits, human HepatoPac kits, rat HepatoPac kits, monkey HepatoPac kits, dog HepatoPac kits, and multi-species HepatoPac kits. It also provides vitro micro-liver cell-based platforms for use in pharmaceutical, safety testing, biotherapeutic and diagnostic product development. Ascendance’ products are created using cell micropatterning technology that plates different cell patterns on industry-standard microwell plates. The company’s products find applications in metabolite identification, preclinical toxicity screening, metabolic stability, transporter-mediated drug uptake and biliary efflux, drug-drug interactions and efficacy assessment. Ascendance is headquartered in Medford, Massachusetts, the US.

Ascendance Biotechnology Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ascendance Biotechnology Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Ascendance Biotechnology Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Ascendance Biotechnology Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Ascendance Biotechnology Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Ascendance Biotechnology Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Ascendance Biotechnology Inc, Medical Equipment, Deal Details 10
Partnerships 10
Ascendance Biotechnology Enters into Licensing Agreement with GE Healthcare 10
Ab Sciex Enters into Co-Marketing Agreement with Hepregen 11
Qualyst Transporter to Enter into Co-Development Agreement with Hepregen 12
Qualyst Transporter Enters Into Technology Integration Agreement With Hepregen 13
Acquisition 14
BioIVT Acquires Ascendance Biotech 14
Ascendance Biotechnology Inc – Key Competitors 15
Ascendance Biotechnology Inc – Key Employees 16
Ascendance Biotechnology Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Ascendance Biotechnology Inc, Medical Equipment, Key Facts 2
Ascendance Biotechnology Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Ascendance Biotechnology Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Ascendance Biotechnology Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Ascendance Biotechnology Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Ascendance Biotechnology Inc, Deals By Market, 2012 to YTD 2018 8
Ascendance Biotechnology Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Ascendance Biotechnology Enters into Licensing Agreement with GE Healthcare 10
Ab Sciex Enters into Co-Marketing Agreement with Hepregen 11
Qualyst Transporter to Enter into Co-Development Agreement with Hepregen 12
Qualyst Transporter Enters Into Technology Integration Agreement With Hepregen 13
BioIVT Acquires Ascendance Biotech 14
Ascendance Biotechnology Inc, Key Competitors 15
Ascendance Biotechnology Inc, Key Employees 16
Ascendance Biotechnology Inc, Other Locations 17

List of Figures
Ascendance Biotechnology Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Ascendance Biotechnology Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Ascendance Biotechnology Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Ascendance Biotechnology Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Ascendance Biotechnology Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Ascendance Biotechnology Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Ascendance Biotechnology Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Ascendance Biotechnology Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Ascendance Biotechnology Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cantel Medical Corp. (CMD)-医療機器分野:企業M&A・提携分析
    Summary Cantel Medical Corp. (Cantel) is a manufacturer and distributor of infection prevention and control products and services to the healthcare market. The company’s product portfolio includes water purification equipment, sterilants, disinfectants and cleaners, specialized medical device reproc …
  • Ellex Medical Lasers Limited (ELX)-医療機器分野:企業M&A・提携分析
    Summary Ellex Medical Lasers Limited (Ellex) is a medical technology company that develops, manufactures, sells and distributes medical equipment for use in ophthalmic procedures. The company also offers a range of third-party medical devices and technologies. Ellex’s product portfolio includes lase …
  • ThromboGenics NV (THR)-製薬・医療分野:企業M&A・提携分析
    Summary ThromboGenics NV (ThromboGenics) is a biotechnology company, which develops and commercializes ophthalmic and cancer medicines. The company’s ocriplasmin, a recombinant derivative of the plasmin protein, is commercialized as Jetrea in the US to treat symptomatic vitreomacular adhesion (VMA) …
  • Kroton Educacional S.A. (KROT3):企業の財務・戦略的SWOT分析
    Kroton Educacional S.A. (KROT3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Fujirebio Europe NV:企業の戦略的SWOT分析
    Fujirebio Europe NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Lendlease Corporation Limited (LLC):企業の財務・戦略的SWOT分析
    Lendlease Corporation Limited (LLC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Leukocare AG-製薬・医療分野:企業M&A・提携分析
    Summary Leukocare AG (Leukocare) is a clinical stage biotechnology company that offers technologies for stabilizing proteins to increase shelf-life and to facilitate terminal sterilization by irradiation or gas. The company offers services such as development of individual SPS formulations meeting i …
  • Constantinou Bros Hotels Ltd:企業の戦略・SWOT・財務情報
    Constantinou Bros Hotels Ltd - Strategy, SWOT and Corporate Finance Report Summary Constantinou Bros Hotels Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Admedes GmbH:企業の戦略的SWOT分析
    Admedes GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Corona Remedies Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Corona Remedies Pvt Ltd (Corona) is a drugs manufacturing company that develops, manufactures, and markets pharmaceutical products. The company’s products include antiallergic drugs, antibiotic drugs, analgesic drugs, antimalarial drugs, heamatonics, hormonal drugs, nutritional supplements, …
  • China Development Bank:企業の戦略・SWOT・財務情報
    China Development Bank - Strategy, SWOT and Corporate Finance Report Summary China Development Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Isofol Medical AB (ISOFOL):製薬・医療:M&Aディール及び事業提携情報
    Summary Isofol Medical AB (Isofol) is a clinical stage pharmaceutical company that develops folate-based therapies for the treatment of cancer patients. The company offers clinical lead candidate Modufolin, a novel folate-based therapy, which is developed to increase the efficacy and reduce the side …
  • Fabric Genomics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Fabric Genomics Inc (Fabric), formerly Omicia Inc, is a healthcare solutions provider that offers genome interpretation solutions. The company offers Opal, a cloud-based informatics platform that helps to analyze and interpret genomes by prioritizing disease-causing variants and genes. Fabri …
  • LM Wind Power Holding AS:企業の戦略的SWOT分析
    LM Wind Power Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Metlifecare Ltd (MET)-製薬・医療分野:企業M&A・提携分析
    Summary Metlifecare Ltd (Metlifecare) is a healthcare service provider that owns and manages retirement villages to older citizens in New Zealand. The center provides retirement villages provide services such as healthcare services, security, community and companionship, maintenance free living and …
  • FLIR Systems Inc:企業の戦略・SWOT・財務情報
    FLIR Systems Inc - Strategy, SWOT and Corporate Finance Report Summary FLIR Systems Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Merit Medical Systems Inc (MMSI):企業の製品パイプライン分析
    Summary Merit Medical Systems Inc (Merit Medical) offers a range of single-use medical devices for interventional and diagnostic procedures. The company’s products include inflation devices and accessories, diagnostic and therapeutic catheters, diagnostic and hydrophilic products, thrombolytic cathe …
  • Cristal Therapeutics BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Cristal Therapeutics BV (Cristal Therapeutics) is a pharmaceutical company that develops nano-medicines for the treatment of cancer and chronic inflammatory disorders. The company develops CriPec docetaxel, a lead product candidate for solid tumours. It also provides peptide-based products, …
  • Guangzhou Pharmaceuticals Corp:企業の戦略的SWOT分析
    Guangzhou Pharmaceuticals Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Myriad Genetics Inc (MYGN):医療機器:M&Aディール及び事業提携情報
    Summary Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. The company’s product portfolio includes molecular diagnostic testing products that analyze genes, t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆